Published • loading... • Updated
Health Canada authorises Abbott's Esprit BTK system for CLTI treatment
Summary by Medical Device Network
1 Articles
1 Articles
Health Canada authorises Abbott's Esprit BTK system for CLTI treatment
Health Canada has granted authorisation for Abbott’s Esprit BTK Everolimus Eluting Resorbable Scaffold System.The post Health Canada authorises Abbott’s Esprit BTK system for CLTI treatment appeared first on Medical Device Network.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium